NovoCure reports Q1 2026 financial results

Filed April 30, 2026 · Period ending April 30, 2026 · ~1 min read

Key Changes

• high

  NovoCure issued a press release on April 30, 2026 announcing financial results for the quarter ended March 31, 2026. Specific metrics are contained in the attached press release.

  Item 2.02 verify on EDGAR →
• medium

  The 8-K filing itself contains no financial details; all Q1 2026 performance data is in the separate press release (Exhibit 99.1).

  8-K: Exhibits verify on EDGAR →